EMMA
EIZAGUIRRE LETAMENDIA
Investigador/a en el periodo 2009-2017
Hospital Universitario de Valme
Sevilla, EspañaPublicaciones en colaboración con investigadoras/es de Hospital Universitario de Valme (2)
2021
-
Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD
Frontiers in Medicine, Vol. 8
-
RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease
Gut, Vol. 70, Núm. 12, pp. 2359-2372